Cargando…
Is there benefit in optimising heart failure treatment in over-80 year-old patients? (HF-80 study): study protocol for a randomized controlled trial
BACKGROUND: An aging population and better management of various heart diseases explain the exponential growth in incidence and prevalence of chronic heart failure, with poor prognosis and heavy health costs. Medical management is codified in international guidelines. The management of heart failure...
Autores principales: | Eschalier, Romain, Jean, Frédéric, Pereira, Bruno, Monzy, Séverine, Vorilhon, Charles, Mactoux, Valérie, Citron, Bernard, Sapin, Vincent, Motreff, Pascal, Lusson, Jean R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310722/ https://www.ncbi.nlm.nih.gov/pubmed/22394464 http://dx.doi.org/10.1186/1745-6215-13-25 |
Ejemplares similares
-
Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies: Different Prognoses?: A Systematic Analytical Review
por: Batisse-Lignier, Marie, et al.
Publicado: (2015) -
Low fibrosis biomarker levels predict cardiac resynchronization therapy response
por: Massoullié, Grégoire, et al.
Publicado: (2019) - 80 años, 80 artistas plásticos, 80 carteles.
-
Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes
por: Pickersgill, Sarah J., et al.
Publicado: (2022) -
Argentina del 80 al 80: balance social y cultural de un siglo /
Publicado: (1993)